Search

Your search keyword '"Roine I"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Roine I" Remove constraint Author: "Roine I"
127 results on '"Roine I"'

Search Results

1. AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2

2. AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2

Catalog

Books, media, physical & digital resources

3. Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design

4. Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2

5. Protein Oxidation Biomarkers and Myeloperoxidase Activation in Cerebrospinal Fluid in Childhood Bacterial Meningitis

6. Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2

7. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ

8. Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile

9. Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists

11. Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design

13. Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5

14. Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile

15. Structure–Affinity Relationships and Structure–Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists

16. Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel

17. Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel

18. Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.

19. Back Cover: Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ (ChemMedChem 2/2016)

20. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ

21. Novel thioamide derivatives as neutral CB1 receptor antagonists

22. Back Cover: Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ (ChemMedChem 2/2016)

25. Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5

26. Adjuvant Glycerol and/or Dexamethasone to Improve the Outcomes of Childhood Bacterial Meningitis: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

29. C-Reactive Protein in Measles

34. Seizures, focal neurological signs, and pneumococcal aetiology associate with impaired consciousness in childhood bacterial meningitis.

35. Clinical Picture and Risk Factors for Poor Outcome in Streptococcus pneumoniae Meningitis of Childhood on Three Continents.

36. Pneumonia in childhood bacterial meningitis-Experience from three continents.

37. Clinical blindness in conjunction with childhood bacterial meningitis.

38. High Concentration of Protein Oxidation Biomarker O-Tyr/Phe Predicts Better Outcome in Childhood Bacterial Meningitis.

39. The Effect of Blood Transfusion on the Survival of Children with Both Severe Anemia and Bacterial Meningitis.

40. Bacterial Meningitis in Children With Sickle Cell Disease in Angola.

41. Unusual Gram-negative bacteria cause more severe bacterial meningitis than the three classical agents in children.

42. Importance of underweight in childhood bacterial meningitis in Finland, Latin America and Angola.

43. Prevalence and significance of anaemia in childhood bacterial meningitis: a secondary analysis of prospectively collected data from clinical trials in Finland, Latin America and Angola.

44. Accuracy of Clinical and Cerebrospinal Fluid Indicators in the Diagnosis of Bacterial Meningitis in Infants <90 Days of Age in Luanda, Angola.

45. Outcome of childhood bacterial meningitis on three continents.

46. Health-related Quality of Life After Childhood Bacterial Meningitis.

47. Extended Continuous β-Lactam Infusion With Oral Acetaminophen in Childhood Bacterial Meningitis: A Randomized, Double-blind Clinical Trial.

48. Risk factors for death in suspected severe bacterial infection in infants aged <90 days in Luanda, Angola.

49. Gene Polymorphisms of TLR4 and TLR9 and Haemophilus influenzae Meningitis in Angolan Children.

50. Aetiology of bacterial meningitis in infants aged <90 days: Prospective surveillance in Luanda, Angola.